http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9721691-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90a0c2c6d4be4b9bf401ee69cb417324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36c593a51c7c8cb5d946a495d6f16310
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1209121735080f517dab9935b194df3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59714be159e79ad5407a0f431f8f1abb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae1f4c64cc2c425bca1339acdcd9f53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0485b381e3a0909a1aaf10167348e614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8a8f16522cbf08213cf1ab3ff3dd6d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b89b06889cb21912f579ad5266a391b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb21d3084207c33ad70d73bd93017e2d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
filingDate 1996-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f80c20968ef46af0576a532049506fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_583e4caad691c9b2d44cc6698a04aa37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b34938d1b03dc4efead82f39b5ce7c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87fdc24acf92a0e9b1902830ad1d2eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dffd1ed4bab1d4a8b8d2be7153375057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c7189271ea3db14ef9d287acff30877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c461bc4c4d2ab76ed83747dcdf37ae28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90b8bb8b805088ea3421a8d900ba0329
publicationDate 1997-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9721691-A1
titleOfInvention Thiazole derivatives
abstract Thiazole derivatives of general formula (I) and salts thereof, exhibiting both leukotriene D4 and thromboxane A2 receptor antagonisms. In formula (I), X is carbonyl or sulfonyl; Y is carboxyl, C1-C5 alkoxycarbonyl or 1H-tetrazol-5-yl; Z is C1-C5 alkyl, C3-C6 cycloalkyl or phenyl; W is C2-C5 alkylene or 1,4-cyclohexylene, and R is optionally subsituted phenylsulfonylamino, phenylsulfonyl, N'-phenylthioureido or C1-C5 alkylsulfonylamino.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009090976-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0999209-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0999209-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011517665-A
priorityDate 1995-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03258759-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04154757-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05279336-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62142168-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H05262736-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID676454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128508701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127901476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427391

Total number of triples: 46.